http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007055921-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d83a3de6aa75024724d0b46f24d1421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be4eba9539585114cd0e90a237a5246a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56538fdeaff2ca759be924e49265513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c020526142c91ceb45db52059d7708e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a049262dab238ee313e7d6746bb58112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90fa90609d3cf2a59e89703e15efd2df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96f13d03cd9f8ca6ca7e50c805d62d88 |
| publicationDate | 2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007055921-A |
| titleOfInvention | Binding agent for vacuolated toxin of Helicobacter pylori |
| abstract | The present invention provides a means for neutralizing the onset of toxicity for the purpose of healing gastritis and gastric ulcer caused by Helicobacter pylori. A binding agent for Helicobacter pylori vacuolated toxin VacA comprising as an active ingredient at least one selected from the group consisting of gangliosides, lyso forms thereof and chemical modifications thereof (gangliosides, etc.), A method for treating or preventing a disease involving the bacterium, characterized by neutralizing VacA activity using a VacA binding agent, a method for treating a disease involving the bacterium characterized by using the VacA binding agent and VacA Use of at least one compound selected from the group consisting of gangliosides, etc., and at least selected from the group consisting of gangliosides, etc., for producing a therapeutic or prophylactic agent screening method, gastritis, gastric ulcer or gastric cancer therapeutic or prophylactic agent The foodstuff which suppresses the effect | action of the said microbe containing 1 type. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012242304-A |
| priorityDate | 2005-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.